1. U.S. Food and Drug Administration. 21 CFR 50.24. Exception from informed consent requirements for emergency research. Federal Register. 1996;61:51528.
2. U.S. Department of Health and Human Services, Food and Drug Administration, Office of Good Clinical Practice, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors: Exception from Informed Consent Requirements for Emergency Research. 2013; https://www.fda.gov/downloads/Regulatoryinformation/Guidances/UCM249673.pdf.
3. Meeting unique requirements: Community consultation and public disclosure for research in emergency setting using exception from informed consent;Dickert;Acad Emerg Med,2021
4. Peri-arrest bolus epinephrine practices amongst pediatric resuscitation experts;Ross;Resusc Plus,2022
5. Physiologic response to pre-arrest bolus dilute epinephrine in the pediatric intensive care unit;Ross;Resuscitation,2018